Overview
Jennifer A. Doudna is a crispr-cas9 specialist with an H-index of 158 at University of California, Berkeley (Faculty). Has been published in Science, Cell, Nature. Based in United States.
Biography
Jennifer Anne Doudna is an American biochemist who has pioneered work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. She received the 2020 Nobel Prize in Chemistry, with Emmanuelle Charpentier, "for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the department of chemistry and the department of molecular and cell biology at the University of California, Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
ScienceCellAnnu Rev Biophys
Key Publications
A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Genome editing. The new frontier of genome engineering with CRISPR-Cas9.
Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.
CRISPR-Cas9 Structures and Mechanisms.
CRISPR technology: A decade of genome editing is only the beginning.
Areas of Expertise
Medical Specialties
Media Archive
